Wuliangyr Group Valuation Report based on the Free Cash Flow of The Firm
- DOI
- 10.2991/978-94-6463-811-0_74How to use a DOI?
- Keywords
- FCFF; intrinsic value; Cost of Capital; Wuliangye Group
- Abstract
With the prosperous development of emerging industries, traditional production like liquor is affected seriously. Wuliangye Group, as the top enterprise in the liquor industry, occupies a significant proportion of the market. Meanwhile, it is still looking for further development and to maintain its status in the market. Therefore, a method that can assess the value and forecast the company’s advancement seems important for the investment. The research applies the free cash flow to the firm (FCFF) model to determine the intrinsic value of Wuliangye’s A-share equity. A comparative analysis between this intrinsic valuation and prevailing market prices informs evidence-based investment strategies. Additionally, the FCFF outcomes elucidate the enterprise’s operational efficiency in cash flow generation and its capacity for enduring value enhancement, thereby establishing a robust evaluative benchmark for stakeholders. In addition, to assess the firm's value precisely, the firm's financial data must be collected from the firm’s financial statement, which the management had published.
- Copyright
- © 2025 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Hanwei Zhang PY - 2025 DA - 2025/08/14 TI - Wuliangyr Group Valuation Report based on the Free Cash Flow of The Firm BT - Proceedings of the 2025 5th International Conference on Enterprise Management and Economic Development (ICEMED 2025) PB - Atlantis Press SP - 706 EP - 716 SN - 2352-5428 UR - https://doi.org/10.2991/978-94-6463-811-0_74 DO - 10.2991/978-94-6463-811-0_74 ID - Zhang2025 ER -